Burden of disease in Germany attributed to ambient particulate matter pollution

IF 1.1 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Herz Pub Date : 2024-09-10 DOI:10.1007/s00059-024-05269-8
Omar Hahad, Jos Lelieveld, Sadeer Al-Kindi, Volker H. Schmitt, Lukas Hobohm, Karsten Keller, Martin Röösli, Marin Kuntic, Andreas Daiber
{"title":"Burden of disease in Germany attributed to ambient particulate matter pollution","authors":"Omar Hahad, Jos Lelieveld, Sadeer Al-Kindi, Volker H. Schmitt, Lukas Hobohm, Karsten Keller, Martin Röösli, Marin Kuntic, Andreas Daiber","doi":"10.1007/s00059-024-05269-8","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Introduction</h3><p>Ambient fine particulate matter pollution with a diameter less than 2.5 micrometers (PM<sub>2.5</sub>) is a significant risk factor for chronic noncommunicable diseases (NCDs), leading to a substantial disease burden, decreased quality of life, and deaths globally. This study aimed to investigate the disease and mortality burdens attributed to PM<sub>2.5</sub> in Germany in 2019.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Data from the Global Burden of Disease (GBD) Study 2019 were used to investigate disability-adjusted life–years (DALYs), years of life lost (YLLs), years lived with disability (YLDs), and deaths attributed to ambient PM<sub>2.5</sub> pollution in Germany.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>In 2019, ambient PM<sub>2.5</sub> pollution in Germany was associated with significant health impacts, contributing to 27,040 deaths (2.82% of total deaths), 568,784 DALYs (2.09% of total DALYs), 135,725 YLDs (1.09% of total YLDs), and 433,058 YLLs (2.92% of total YLLs). The analysis further revealed that cardiometabolic and respiratory conditions, such as ischemic heart disease, stroke, chronic obstructive pulmonary disease, lung cancer, and diabetes mellitus, were the leading causes of mortality and disease burden associated with ambient PM<sub>2.5</sub> pollution in Germany from 1990–2019. Comparative assessments between 1990 and 2019 underscored ambient PM<sub>2.5</sub> as a consistent prominent risk factor, ranking closely with traditional factors like smoking, arterial hypertension, and alcohol use contributing to deaths, DALYs, YLDs, and YLLs.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Ambient PM<sub>2.5</sub> pollution is one of the major health risk factors contributing significantly to the burden of disease and mortality in Germany, emphasizing the urgent need for targeted interventions to address its substantial contribution to chronic NCDs.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Herz","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00059-024-05269-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Ambient fine particulate matter pollution with a diameter less than 2.5 micrometers (PM2.5) is a significant risk factor for chronic noncommunicable diseases (NCDs), leading to a substantial disease burden, decreased quality of life, and deaths globally. This study aimed to investigate the disease and mortality burdens attributed to PM2.5 in Germany in 2019.

Methods

Data from the Global Burden of Disease (GBD) Study 2019 were used to investigate disability-adjusted life–years (DALYs), years of life lost (YLLs), years lived with disability (YLDs), and deaths attributed to ambient PM2.5 pollution in Germany.

Results

In 2019, ambient PM2.5 pollution in Germany was associated with significant health impacts, contributing to 27,040 deaths (2.82% of total deaths), 568,784 DALYs (2.09% of total DALYs), 135,725 YLDs (1.09% of total YLDs), and 433,058 YLLs (2.92% of total YLLs). The analysis further revealed that cardiometabolic and respiratory conditions, such as ischemic heart disease, stroke, chronic obstructive pulmonary disease, lung cancer, and diabetes mellitus, were the leading causes of mortality and disease burden associated with ambient PM2.5 pollution in Germany from 1990–2019. Comparative assessments between 1990 and 2019 underscored ambient PM2.5 as a consistent prominent risk factor, ranking closely with traditional factors like smoking, arterial hypertension, and alcohol use contributing to deaths, DALYs, YLDs, and YLLs.

Conclusion

Ambient PM2.5 pollution is one of the major health risk factors contributing significantly to the burden of disease and mortality in Germany, emphasizing the urgent need for targeted interventions to address its substantial contribution to chronic NCDs.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
环境颗粒物污染造成的德国疾病负担
导言:直径小于 2.5 微米(PM2.5)的环境细颗粒物污染是慢性非传染性疾病(NCD)的重要风险因素,在全球范围内导致大量疾病负担、生活质量下降和死亡。本研究旨在调查2019年德国PM2.5导致的疾病和死亡负担。方法利用2019年全球疾病负担(GBD)研究的数据,调查环境PM2.5污染导致的残疾调整生命年(DALYs)、丧失生命年(YLLs)、残疾生活年(YLDs)和死亡。结果2019年,德国的环境PM2.5污染对健康造成了重大影响,导致27040人死亡(占总死亡人数的2.82%)、568784人残疾调整寿命年(占总残疾调整寿命年的2.09%)、135725人残疾寿命年(占总残疾寿命年的1.09%)和433058人残疾寿命年(占总残疾寿命年的2.92%)。分析进一步显示,1990-2019年期间,缺血性心脏病、中风、慢性阻塞性肺病、肺癌和糖尿病等心脏代谢疾病和呼吸系统疾病是德国与环境PM2.5污染相关的主要死亡原因和疾病负担。1990 年和 2019 年之间的比较评估突出表明,环境 PM2.5 始终是一个突出的风险因素,与吸烟、动脉高血压和饮酒等造成死亡、DALYs、YLDs 和 YLLs 的传统因素密切相关。结论环境 PM2.5 污染是造成德国疾病负担和死亡率的主要健康风险因素之一,强调迫切需要采取有针对性的干预措施,以解决其对慢性非传染性疾病的重大影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Herz
Herz 医学-心血管系统
CiteScore
3.00
自引率
5.90%
发文量
61
审稿时长
4-8 weeks
期刊介绍: Herz is the high-level journal for further education for all physicians interested in cardiology. The individual issues of the journal each deal with specific topics and comprise review articles in English and German written by competent and esteemed authors. They provide up-to-date and comprehensive information concerning the speciality dealt with in the issue. Due to the fact that all relevant aspects of the pertinent topic of an issue are considered, an overview of the current status and progress in cardiology is presented. Reviews and original articles round off the spectrum of information provided.
期刊最新文献
Guideline-endorsed follow-up after percutaneous valve therapies-non-attendance of TAVI and MitraClip patients. [Healthcare 4.0-Medicine in transition]. Artificial intelligence in cardiovascular imaging and intervention. [Diagnostics and treatment of syncope]. [Telemedical care concepts for heart failure: status and future].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1